Concord Drugs Limited (BOM:538965)
India · Delayed Price · Currency is INR 82.39
+1.09 (1.34%)
At close: Apr 16, 2026
Concord Drugs Market Cap
Concord Drugs has a market cap or net worth of 1.09 billion as of April 16, 2026. Its market cap has increased by 223.16% in one year.
Market Cap
1.09B
Enterprise Value
1.27B
Revenue
512.41M
Ranking
n/a
PE Ratio
181.25
Stock Price
82.39
Market Cap Chart
Since February 23, 2015, Concord Drugs's market cap has increased from 144.80M to 1.09B, an increase of 649.63%. That is a compound annual growth rate of 19.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 1.09B | -0.11% |
| Dec 31, 2025 | 1.09B | 188.24% |
| Dec 31, 2024 | 377.00M | -36.87% |
| Dec 29, 2023 | 597.20M | 109.83% |
| Dec 30, 2022 | 284.61M | 1.24% |
| Dec 31, 2021 | 281.11M | 40.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coral Laboratories | 1.44B |
| Speciality Medicines | 1.43B |
| Bal Pharma | 1.19B |
| Lactose (India) | 1.15B |
| Pharmaids Pharmaceuticals | 1.09B |
| Mercury Laboratories | 924.00M |
| Makers Laboratories | 919.28M |
| Accretion Pharmaceuticals | 824.25M |